Skip to content

LGND LIGAND PHARMACEUTICALS INC

Follow

COM NEW (common), issuer CIK 886163

403 managers (417 13F filers) reported a position in LGND shares at 2026-06-30, 22,625,881 shares in all. 94 filers opened a position and 34 filers sold out during the quarter.

Managers
403
13F filers
417
New
94
Added
151
Reduced
114
Sold out
34
Shares held by filers
22,625,881

Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.

13D and 13G filers

No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.

Insider trades

The latest Form 4 transactions, non-derivative.
OwnerDateSharesPriceFiling
Reardon Andrewofficer (CLO & Secretary)2026-10-02-17 S$307.74Form 4
Reardon Andrewofficer (CLO & Secretary)2026-10-02-235 S$307.1911Form 4
Reardon Andrewofficer (CLO & Secretary)2026-10-02-404 S$306.1834Form 4
Reardon Andrewofficer (CLO & Secretary)2026-10-02-1,535 S$304.5154Form 4
Reardon Andrewofficer (CLO & Secretary)2026-10-02-1,976 S$303.5444Form 4
Reardon Andrewofficer (CLO & Secretary)2026-10-02-833 S$302.5107Form 4
Reardon Andrewofficer (CLO & Secretary)2026-10-02+340 M$52.27Form 4

13F holders, Q2 2026

Filers in the available 13F reports with a share position at 2026-06-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
Davis Capital Management1$316<0.01%new13F-HRTimeline
Inspire Investing, LLCgroup of 2 filers holding1$199-2,069Timeline
Evolution Advisers, Inc.2$00%new13F-HRTimelineValue filed as zero, left out of ratios.

Events

  • Reardon Andrew disposed of 4,660 LGND shares on 2026-10-02, Form 4 filed 2026-10-06. 0001950232-26-000003

    Accepted , ingested